Cystografin Dilute
(Diatrizoate Meglumine)Cystografin Dilute Prescribing Information
Cystografin Dilute is indicated
for retrograde cystourethrography.
the night before the examination and a low residue diet the day before
the procedure are recommended.
This preparation is contraindicated
in patients with a hypersensitivity to salts of diatrizoic acid.
Retrograde genitourinary procedures
may cause such complications as hematuria, perforation of the urethra
or bladder, introduction of infection into the genitourinary tract,
and oliguria or anuria.
If intravasation of this drug occurs, the reactions which may be
associated with intravenous administration may possibly be encountered.
Hypersensitivity or anaphylactoid reactions may occur. Severe reactions
may be manifested by edema of the face and glottis, respiratory distress,
convulsions or shock; such reactions may prove fatal unless promptly
controlled by such emergency measures as maintenance of a clear airway
and immediate use of oxygen and resuscitative drugs.
tests indicative of hypothyroidism or transient thyroid suppression
have been uncommonly reported following iodinated contrast media administration
to adult and pediatric patients, including infants. Some patients
were treated for hypothyroidism.
Cystografin Dilute (Diatrizoate
Meglumine Injection USP 18%) is a radiopaque contrast agent supplied
as a sterile, aqueous solution. Each mL provides 180 mg diatrizoate
meglumine with 0.4 mg edetate disodium as a sequestering agent. Each
mL of solution also contains approximately 85 mg organically bound
iodine. At the time of manufacture, the air in the container is replaced
by nitrogen.
Cystografin Dilute (Diatrizoate
Meglumine Injection USP 18%) is available in packages of ten 300 mL
bottIes (NDC 0270-1410-30).